CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 39 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2024 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2023 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q3 2023 | $20 | – | 13,682 | +1368100.0% | 0.00% | – |
Q2 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
Q1 2023 | $0 | – | 1 | 0.0% | 0.00% | – |
Q4 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
Q2 2022 | $10,000 | -44.4% | 9,671 | -12.8% | 0.00% | – |
Q1 2022 | $18,000 | -67.9% | 11,096 | -52.1% | 0.00% | – |
Q4 2021 | $56,000 | – | 23,186 | +2318500.0% | 0.00% | – |
Q3 2021 | $0 | – | 1 | -75.0% | 0.00% | – |
Q2 2021 | $0 | -100.0% | 4 | -99.3% | 0.00% | – |
Q1 2021 | $2,000 | – | 537 | +13325.0% | 0.00% | – |
Q4 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q3 2020 | $0 | -100.0% | 4 | -99.8% | 0.00% | – |
Q2 2020 | $6,000 | – | 2,209 | +19981.8% | 0.00% | – |
Q1 2020 | $0 | – | 11 | -52.2% | 0.00% | – |
Q4 2019 | $0 | – | 23 | -69.7% | 0.00% | – |
Q3 2019 | $0 | -100.0% | 76 | -99.4% | 0.00% | – |
Q2 2019 | $51,000 | +218.8% | 13,632 | +241.2% | 0.00% | – |
Q1 2019 | $16,000 | – | 3,995 | +2693.7% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 143 | -97.3% | 0.00% | – |
Q3 2018 | $46,000 | +283.3% | 5,280 | +417.6% | 0.00% | – |
Q2 2018 | $12,000 | -55.6% | 1,020 | -56.9% | 0.00% | – |
Q1 2018 | $27,000 | +58.8% | 2,367 | +48.5% | 0.00% | – |
Q4 2017 | $17,000 | +142.9% | 1,594 | +246.5% | 0.00% | – |
Q3 2017 | $7,000 | – | 460 | +1079.5% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 39 | -66.1% | 0.00% | – |
Q1 2017 | $2,000 | 0.0% | 115 | -28.1% | 0.00% | – |
Q4 2016 | $2,000 | – | 160 | +661.9% | 0.00% | – |
Q3 2016 | $0 | – | 21 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ADAMS STREET PARTNERS LLC | 2,687,381 | $38,430,000 | 10.58% |
Novo Holdings A/S | 3,224,046 | $46,104,000 | 4.39% |
SPHERA FUNDS MANAGEMENT LTD. | 320,229 | $4,579,000 | 1.16% |
Orbimed Advisors | 5,379,349 | $76,925,000 | 0.98% |
Avoro Capital Advisors LLC | 216,619 | $3,098,000 | 0.63% |
Rock Springs Capital Management LP | 450,000 | $6,435,000 | 0.43% |
Cormorant Asset Management, LP | 198,526 | $2,839,000 | 0.38% |
EverPoint Asset Management, LLC | 417,849 | $5,975,000 | 0.11% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 21,292 | $304,000 | 0.05% |
PRELUDE CAPITAL MANAGEMENT, LLC | 9,402 | $134,000 | 0.02% |